Cargando…

High expression of PTPN21 in B-cell non-Hodgkin's gastric lymphoma, a positive mediator of STAT5 activity

Detalles Bibliográficos
Autores principales:	Plani-Lam, J H C, Chow, T C, Fan, Y-H, Garcia-Bloj, B, Cheng, L, Jin, D Y, Hancock, W, Fanayan, S, Ingley, E, Song, Y-Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742624/ https://www.ncbi.nlm.nih.gov/pubmed/26771814 http://dx.doi.org/10.1038/bcj.2015.107

Ejemplares similares

Primary gastric Hodgkin's lymphoma
por: Hossain, Fahad S, et al.
Publicado: (2007)

Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2022)

BRAF mutations in non-Hodgkin's lymphoma
por: Lee, J W, et al.
Publicado: (2003)

Primary gastric Hodgkin's lymphoma
por: Jung, Ji-Han, et al.
Publicado: (2012)

Gastric non-Hodgkin’s lymphoma
por: Tzimourtos, Vassilios, et al.
Publicado: (2014)

Non-Hodgkin's Lymphoma: CME Lecture
por: Hancock, Barry W
Publicado: (1995)

EBV in situ hybridization study for non-Hodgkin's lymphomas.
por: Ko, Y. H., et al.
Publicado: (1994)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin Lymphoma
por: Henrickson, Sarah E., et al.
Publicado: (2019)

Retroperitoneal extra-adrenal non-Hodgkin lymphoma: An uncommon presentation
por: Ayari, Y., et al.
Publicado: (2018)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
por: Lam, Selay, et al.
Publicado: (2011)

PTPN11 hypomethylation is associated with gastric cancer progression
por: Xu, Lele, et al.
Publicado: (2020)

Mitochondrial DNA Fragmentation and Risk of Non-Hodgkin Lymphoma
por: Hosgood, H. Dean, et al.
Publicado: (2023)

HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells
por: Schoof, Nils, et al.
Publicado: (2009)

Prognostic value and immunological role of PTPN21 in pan-cancer analysis
por: Yang, YanE, et al.
Publicado: (2023)

Synchronous Double Malignant Tumors Consisting of Stomach and Hodgkin's Lymphoma with Collision between Gastric Adenocarcinoma and Hodgkin's Lymphoma in the Stomach
por: Yanagawa, Naoki, et al.
Publicado: (2012)

Primary T-Cell Non-Hodgkin Lymphoma of the Vagina
por: Herraiz, J. L., et al.
Publicado: (2015)

Clinicopathologic and immunophenotypic study of non-Hodgkin's lymphoma in Korea. Lymphoreticular Study Group of the Korean Society of Pathologists.
por: Kim, C. W., et al.
Publicado: (1992)

Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma
por: Demosthenous, Christos, et al.
Publicado: (2015)

EBV-positive Hodgkin lymphoma is associated with suppression of p21(cip1/waf1 )and a worse prognosis
por: Liu, Ting-Yun, et al.
Publicado: (2010)

Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer
por: Zhang, Bing‐Dong, et al.
Publicado: (2019)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

Primary non-Hodgkin lymphoma of liver
por: Masood, A., et al.
Publicado: (2009)

Genetic susceptibility to therapy-related leukemia after Hodgkin lymphoma or non-Hodgkin lymphoma: role of drug metabolism, apoptosis and DNA repair
por: Ding, Y, et al.
Publicado: (2012)

Imaging features of extranodal involvement in paediatric Hodgkin lymphoma
por: Spijkers, Suzanne, et al.
Publicado: (2018)

Gastric mucosa-associated lymphoid tissue lymphoma associated with pancreatic non-Hodgkin's lymphoma: A case report
por: Okasha, H., et al.
Publicado: (2014)

The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
por: Derenzini, E, et al.
Publicado: (2011)

The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
por: Derenzini, E, et al.
Publicado: (2014)

Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998)

Increasing incidence of non-Hodgkin lymphoma in England, 1985–2019
por: Bawa, M, et al.
Publicado: (2023)

p21 expression and mutation in gastric carcinoma: analysis by immunohistochemistry and PCR-SSCP.
por: Park, Y. E., et al.
Publicado: (1998)

PCR clonality detection in Hodgkin lymphoma
por: Hebeda, K. M., et al.
Publicado: (2009)

Association of Genetic Polymorphisms in STAT 3, STAT 5b and GWAS Identified PTPN22 Gene with Rheumatic Heart Disease
por: Gupta, Usha, et al.
Publicado: (2014)

Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women
por: Morton, L M, et al.
Publicado: (2003)

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis
por: Diaz, Tania, et al.
Publicado: (2011)

Post-treatment parenthood in Hodgkin's lymphoma survivors
por: Kiserud, C E, et al.
Publicado: (2007)

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
por: Baumgartner, Christina K., et al.
Publicado: (2023)

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B(5b )(CYB5B)
por: Murphy, Derek, et al.
Publicado: (2010)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab
por: Law, Jennie Y, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d7glvh3kaqt75eo411joa6tm94